An anonymous director reports
AVICANNA ANNOUNCES CHANGE OF AUDITOR
Avicanna Inc. has appointed Kingston Ross Pasnak LLP as its independent registered public accounting firm, effective July 15, 2021, to hold office until the next annual meeting of the shareholders of the company. The successor auditor was appointed following the resignation of MNP LLP as the company's independent registered public accounting firm.
There were no reservations or modified opinions in the former auditor's audit report for the fiscal year ended Dec. 31, 2019. However, there is a reportable event with respect to an unresolved issue, as such terms are defined in National Instrument 51-102 -- Continuous Disclosure Obligations (NI 51-102), related to the audit of the company's financial statements for the year ended Dec. 31, 2020, as the internal control issues it identified are such that the former auditor has concluded that it will not be in a position to issue an opinion on 2020 financial statements. The company has authorized the former auditor to respond fully to inquiries by the successor auditor concerning the issue.
The change of the auditor and the recommendation to appoint the successor auditor were approved by the audit committee and the board of directors of the company. In accordance with NI 51-102, the notice of change of auditor, together with the required letters from the former auditor and the successor auditor, have been reviewed by the board of directors of the company and filed on SEDAR.
Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development and commercialization of plant-derived cannabinoid-based products for the global consumer, medical and pharmaceutical market segments.
We seek Safe Harbor.
© 2022 Canjex Publishing Ltd. All rights reserved.